UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective

Kidney international, 2006-07, Vol.70 (1), p.26-33

Zoccali, C.

2006

Volltextzugriff (PDF)

Low triiodothyronine and survival in end-stage renal disease

Kidney international, 2006-08, Vol.70 (3), p.523-528

2006

Volltextzugriff (PDF)

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

Nephrology, dialysis, transplantation, 2003-07, Vol.18 (7), p.1272-1280

2003

Volltextzugriff (PDF)

Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry

Nephrology, dialysis, transplantation, 2014-02, Vol.29 (2), p.232-239

2014

Volltextzugriff (PDF)

Asymmetric dimethylarginine in end-stage renal disease patients: A biomarker modifiable by calcium blockade and angiotensin II antagonism?

Kidney international, 2006-12, Vol.70 (12), p.2053-2055

Zoccali, C.

2006

Volltextzugriff (PDF)

Obesity and kidney disease: hidden consequences of the epidemic

Brazilian journal of medical and biological research, 2017-01, Vol.50 (5), p.e6075-e6075

2017

Volltextzugriff (PDF)

Obesity and kidney disease: Hidden consequences of the epidemic

Physiology international, 2017-03, Vol.104 (1), p.1

2017

Volltextzugriff (PDF)

Glitazones in chronic kidney disease: Potential and concerns

Nutrition, metabolism, and cardiovascular diseases, 2012-03, Vol.22 (3), p.167-175

2012

Volltextzugriff (PDF)

General and clinical epidemiology at square two: A new educational series for the renal physician

Kidney international, 2007-08, Vol.72 (4), p.411-411

Zoccali, C.

2007

Volltextzugriff (PDF)

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

Journal of the American Society of Nephrology, 2002, Vol.13 (1), p.134-141

2002

Volltextzugriff (PDF)

Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients

Journal of the American Society of Nephrology, 2001-11, Vol.12 (11), p.2458-2464

2001

Volltextzugriff (PDF)

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients

Nutrition, metabolism, and cardiovascular diseases, 2012-11, Vol.22 (11), p.981-988

2012

Volltextzugriff (PDF)

Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis

Nephrology, dialysis, transplantation, 2007-02, Vol.22 (2), p.538-544

2007

Volltextzugriff (PDF)

Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease

Nephrology, dialysis, transplantation, 2004-08, Vol.19 (suppl-5), p.v67-v72

2004

Volltextzugriff (PDF)

Serum Phosphorus Levels are Associated with Endothelial Dysfunction in Hypertensive Patients

Nutrition, metabolism, and cardiovascular diseases, 2016-08, Vol.26 (8), p.683-688

2016

Volltextzugriff (PDF)

Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention

Nephrology, dialysis, transplantation, 2002-01, Vol.17 (suppl-11), p.50-54

ZOCCALI, Carmine

2002

Volltextzugriff (PDF)

An introduction to inverse probability of treatment weighting in observational research

Clinical kidney journal, 2022-01, Vol.15 (1), p.14-20

2022

Volltextzugriff (PDF)

Obesity in CKD—What Should Nephrologists Know?

Journal of the American Society of Nephrology, 2013-11, Vol.24 (11), p.1727-1736

2013

Volltextzugriff (PDF)

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)

Nutrition, metabolism, and cardiovascular diseases, 2012-09, Vol.22 (9), p.748-755

2012

Volltextzugriff (PDF)

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

The Lancet (British edition), 2014-05, Vol.383 (9931), p.1831-1843

2014

Volltextzugriff (PDF)

Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention

Kidney international, 2006-02, Vol.69 (3), p.538-545

2006

Volltextzugriff (PDF)

A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study

Oxidative medicine and cellular longevity, 2016-01, Vol.2016 (1), p.1507270-1507270

2016

Volltextzugriff (PDF)

Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease

Nephrology, dialysis, transplantation, 2015-03, Vol.30 (3), p.352-357

2015

Volltextzugriff (PDF)

Homocysteine and risk in end-stage renal disease: a matter of context

Kidney international, 2006-01, Vol.69 (2), p.204-206

2006

Volltextzugriff (PDF)

Sleep Disordered Breathing in Renal Transplant Patients

American journal of transplantation, 2009-06, Vol.9 (6), p.1373-1381

2009

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(113)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(107)
Science & Technology
(105)
Life Sciences & Biomedicine
(104)
Urology & Nephrology
(73)
Female
(51)
Male
(49)
Middle Aged
(47)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Aged
(37)
Adult
(30)
Kidney Failure, Chronic - Complications
(29)
Nephrology. Urinary Tract Diseases
(27)
Kidney Failure, Chronic - Therapy
(26)
Cardiovascular System & Cardiology
(23)
Kidney Failure, Chronic - Mortality
(22)
Cardiovascular Risk
(21)
Dialysis
(21)
Transplantation
(21)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective

Low triiodothyronine and survival in end-stage renal disease

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry

Asymmetric dimethylarginine in end-stage renal disease patients: A biomarker modifiable by calcium blockade and angiotensin II antagonism?

Obesity and kidney disease: hidden consequences of the epidemic

Obesity and kidney disease: Hidden consequences of the epidemic

Glitazones in chronic kidney disease: Potential and concerns

General and clinical epidemiology at square two: A new educational series for the renal physician

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients

Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis

Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease

Serum Phosphorus Levels are Associated with Endothelial Dysfunction in Hypertensive Patients

Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention

An introduction to inverse probability of treatment weighting in observational research

Obesity in CKD—What Should Nephrologists Know?

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention

A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study

Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease

Homocysteine and risk in end-stage renal disease: a matter of context

Sleep Disordered Breathing in Renal Transplant Patients

Aktive Filter

Suchergebnisse filtern